CryoPort (CYRX) Stock Price, News & Analysis

Company Overview

CryoPort, Inc. (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms. These solutions enable uninterrupted maintenance of ultra-low temperatures during transit, while providing customers with transparency and compliance documentation. In addition to specialized containers for liquid nitrogen-based shipments, CryoPort offers on-demand logistics services, temperature excursion management and supply chain optimization tools via its cloud-based CryoPortal platform.

Leveraging a global network of logistics partners, CryoPort delivers services across North America, Europe, Asia-Pacific and Latin America. The company’s 24/7 operations and qualified service centers help streamline regulatory requirements and minimize risk for research institutions, pharmaceutical and biotechnology companies, contract research organizations and cell therapy manufacturers. CryoPort continues to expand its infrastructure and technology offerings to support the growing demand for advanced therapy supply chains worldwide.

Key Stats

• Today's Range: $11.62 to $13.10
• 50-Day Range: $7.72 to $12.19
• 52-Week Range: $5.31 to $13.10
• Volume: 599,585 shs
• Average Volume: 429,815 shs
• Market Capitalization: $635.28 million
• P/E Ratio: 9.36
• Dividend Yield: N/A
• Price Target: $14.44
• Consensus Rating: Moderate Buy

CryoPort Stock Analysis - MarketRank™

CryoPort scored higher than 66% of companies evaluated by MarketBeat, and ranked 43rd out of 129 stocks in the transportation sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CryoPort has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 8 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

CryoPort has a consensus price target of $14.44, representing about 13.7% upside from its current price of $12.70.

Amount of Analyst Coverage

CryoPort has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for CryoPort are expected to grow in the coming year, from ($0.73) to ($0.63) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CryoPort is 9.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.36.

Price to Earnings Ratio vs. Sector

The P/E ratio of CryoPort is 9.41, which means that it is trading at a less expensive P/E ratio than the Transportation sector average P/E ratio of about 22.96.

Price to Book Value per Share Ratio

CryoPort has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CYRX.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CryoPort does not currently pay a dividend.

Dividend Growth

CryoPort does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.12

News Sentiment

CryoPort has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Transportation companies.

News Coverage This Week

MarketBeat has tracked 18 news articles for CryoPort this week, compared to 3 articles on an average week.

Search Interest

2 people have searched for CYRX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CryoPort insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $471,183.00 in company stock.

Percentage Held by Insiders

10.10% of the stock of CryoPort is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

92.90% of the stock of CryoPort is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CYRX Stock Analysis - Frequently Asked Questions

How have CYRX shares performed this year?

CryoPort's stock was trading at $9.60 at the beginning of 2026. Since then, CYRX shares have increased by 32.3% and is now trading at $12.7030.

How were CryoPort's earnings last quarter?

CryoPort, Inc. (NASDAQ:CYRX) posted its quarterly earnings data on Monday, May, 4th. The company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $0.03. The company had revenue of $47.80 million for the quarter, compared to the consensus estimate of $44.86 million. CryoPort had a negative trailing twelve-month return on equity of 7.84% and a net margin of 41.57%.
Read the conference call transcript.

Is CryoPort doing a stock buyback?

CryoPort's board authorized a share repurchase program on Tuesday, August 6th 2024, which authorizes the company to buy back $200,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 49.1% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board of directors believes its stock is undervalued.

Who are CryoPort's major shareholders?

Top institutional investors of CryoPort include Assenagon Asset Management S.A. (3.00%), Bank of New York Mellon Corp (0.40%), Penbrook Management LLC (0.37%) and Geneos Wealth Management Inc. (0.10%). Insiders that own company stock include Jerrell Shelton, Robert Stefanovich, Edward J Zecchini, Mark W Sawicki, Richard J Berman, Ramkumar Mandalam and Robert J Hariri.
View institutional ownership trends.

How do I buy shares of CryoPort?

Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CryoPort own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoPort investors own include American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Humana (HUM).

Company Calendar

• Last Earnings: 5/04/2026
• Today: 5/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Transportation
• Industry: TRANS - SERVICES
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CYRX
• CIK: 1124524
• Web: www.cryoport.com
• Phone: (949) 470-2300
• Fax: 949-470-2306
• Employees: 1,186
• Year Founded: 1999

Price Target and Rating

• Average Price Target for CryoPort: $14.44
• High Price Target: $17.00
• Low Price Target: $12.00
• Potential Upside/Downside: +13.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.78
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.32
• Trailing P/E Ratio: 9.41
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $78.30 million
• Net Margins: 41.57%
• Pretax Margin: -18.26%
• Return on Equity: -7.84%
• Return on Assets: -4.78%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.17
• Quick Ratio: 2.07

Sales & Book Value

• Annual Sales: $176.18 million
• Price / Sales: 3.62
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.19 per share
• Price / Book: 1.38

Miscellaneous

• Outstanding Shares: 50,200,000
• Free Float: 45,128,000
• Market Cap: $637.69 million
• Optionable: Optionable
• Beta: 1.75